Last quarter (Q ), Acura Pharmaceuticals's total revenue was $270.00K, a decrease of -34.15% from the same quarter last year. In Q, Acura Pharmaceuticals's net income was $-262.00K. See Acura Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 20	Dec 19	Dec 18	Dec 17	Dec 16
Total Revenue	$ 2.25M	$ 3.57M	$ 2.66M	$ 410.00K	$ 2.97M	$ 4.46M
Cost of Revenue	-	-	-	$ 0.00	$ 128.00K	$ 451.00K
Gross Profit	-	-	-	$ 410.00K	$ 2.84M	$ 4.01M
Operating Expense	$ 3.35M	$ 4.33M	$ 3.38M	$ 4.33M	$ 8.06M	$ 10.57M
Operating Income	$ -1.11M	$ -758.00K	$ -725.00K	$ -3.92M	$ -5.22M	$ -6.56M
Net Non Operating Interest Income Expense	$ -312.00K	$ -450.00K	$ -449.00K	$ -223.00K	$ -592.00K	$ -833.00K
Other Income Expense	$ 269.00K	-	$ -2.60M	$ 296.00K	-	$ 2.00K
Pretax Income	$ -1.15M	$ -1.21M	$ -3.77M	$ -3.84M	$ -5.82M	$ -7.39M
Tax Provision	-	$ 0.00	$ 0.00	$ 0.00	$ -135.00K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -1.15M	$ -1.21M	$ -3.77M	$ -3.84M	$ -5.68M	$ -7.39M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 3.35M	$ 4.33M	$ 3.38M	$ 4.33M	$ 8.19M	$ 11.02M
Net Income From Continuing And Discontinued Operation	$ -1.15M	$ -1.21M	$ -3.77M	$ -3.84M	$ -5.68M	$ -7.39M
Normalized Income	$ -1.42M	$ -1.21M	$ -1.17M	$ -4.14M	$ -5.68M	$ -7.39M
Interest Expense	$ 312.00K	$ 450.00K	$ 462.00K	$ 395.00K	$ 596.00K	$ 893.00K
EBIT	$ -839.00K	$ -758.00K	$ -3.31M	$ -3.45M	$ -5.22M	$ -6.50M
EBITDA	$ -757.00K	$ -633.00K	$ -3.04M	$ -3.17M	$ -4.93M	$ -6.15M

Currency in USD

Acura Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing